Huntington's Disease News and Research

Latest Huntington's Disease News and Research

Insight into neurodegenerative diseases

Insight into neurodegenerative diseases

Alnylam to extend RNAi therapeutics research collaboration with AlCana and UBC

Alnylam to extend RNAi therapeutics research collaboration with AlCana and UBC

Neuralstem to present HSSC Phase I trial data in amyotrophic lateral sclerosis at AAN meeting

Neuralstem to present HSSC Phase I trial data in amyotrophic lateral sclerosis at AAN meeting

Alnylam defends against Tekmira complaint, files answer and counterclaim

Alnylam defends against Tekmira complaint, files answer and counterclaim

New insight into Huntington's disease

New insight into Huntington's disease

Huntingtin protein is responsible for metabolic imbalances in hypothalamus

Huntingtin protein is responsible for metabolic imbalances in hypothalamus

Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

Study identifies unique adult animal stem cells that can turn into neurons

Study identifies unique adult animal stem cells that can turn into neurons

Xenon founder receives Canada Wightman Award for leadership in medical science

Xenon founder receives Canada Wightman Award for leadership in medical science

Cortex reports net loss of $0.01 per share for quarter ended December 31, 2010

Cortex reports net loss of $0.01 per share for quarter ended December 31, 2010

Study reveals new mechanism underlying reproduction in plants

Study reveals new mechanism underlying reproduction in plants

Alnylam to defend against Tekmira complaint

Alnylam to defend against Tekmira complaint

The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD

The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD

Protein folding may aid in developing new therapies for brain diseases

Protein folding may aid in developing new therapies for brain diseases

Global settlement agreement reached in Tuschl patents litigation

Global settlement agreement reached in Tuschl patents litigation

Study identifies potential therapeutic target for neurodegenerative disorders

Study identifies potential therapeutic target for neurodegenerative disorders

New discovery: GPCR family of proteins can recognize and respond to wide array of signals

New discovery: GPCR family of proteins can recognize and respond to wide array of signals

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

Neuralstem announces initiation of NSI-189 Phase Ia trial for major depressive disorder

New DNA microarray detects genetic changes differentiating cancer patients from healthy individuals

New DNA microarray detects genetic changes differentiating cancer patients from healthy individuals

Breakthrough in Huntington's disease may give patients hope for cure

Breakthrough in Huntington's disease may give patients hope for cure

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.